| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 766 |
| 1 | PREDNISONE | 641 |
| 2 | TACROLIMUS | 587 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 552 |
| 4 | TACROLIMUS OINTMENT 0.1% | 552 |
| 5 | ADALIMUMAB | 476 |
| 6 | MYCOPHENOLATE MOFETIL | 458 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 458 |
| 8 | DEXAMETHASONE | 421 |
| 9 | DEXAMETHASONE 1.5 MG | 421 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 75 | 0.0348 |
| 1 | ACITRETIN | 58 | 0.0118 |
| 2 | ERGOCALCIFEROL | 345 | 0.0116 |
| 3 | VORICONAZOLE | 336 | 0.0109 |
| 4 | VEMURAFENIB | 120 | 0.0100 |
| 5 | AXICABTAGENE CILOLEUCEL | 99 | 0.0097 |
| 6 | SIROLIMUS | 120 | 0.0088 |
| 7 | VALGANCICLOVIR | 100 | 0.0052 |
| 8 | EVEROLIMUS TABLETS | 87 | 0.0051 |
| 9 | TACROLIMUS OINTMENT 0.1% | 552 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1472 |
| 1 | Thalidomide Analog [EPC] | 825 |
| 2 | Kinase Inhibitor [EPC] | 745 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 659 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 473 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 414 |
| 6 | Janus Kinase Inhibitor [EPC] | 399 |
| 7 | Azole Antifungal [EPC] | 394 |
| 8 | Vitamin C [EPC] | 382 |
| 9 | Provitamin D2 Compound [EPC] | 345 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 44 | 0.0387 |
| 1 | Photoactivated Radical Generator [EPC] | 4 | 0.0312 |
| 2 | Antileishmanial [EPC] | 7 | 0.0180 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 91 | 0.0155 |
| 4 | Provitamin D2 Compound [EPC] | 345 | 0.0116 |
| 5 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 99 | 0.0097 |
| 7 | Tubulin Inhibiting Agent [EPC] | 2 | 0.0069 |
| 8 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 23 | 0.0044 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 91 | 0.0041 |